Kaleyra, Inc. Balance Sheet | Understand Stock

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020	Q1 FY2020 As of Mar 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q3 FY2019 As of Sep 30, 2019	Q2 FY2019 As of Jun 30, 2019	Q1 FY2019 As of Mar 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q3 FY2018 As of Sep 30, 2018
ASSETS
Current assets:
Cash
Receivable from related party
Cash and cash equivalents
Restricted cash
Short-term marketable securities
Short-term investments
Trade receivables, net
Deferred cost
Prepaid expenses
Other current assets
Total current assets

Cash and marketable securities held in Trust Account
Interest receivable on cash and marketable securities held in Trust Account
Property and equipment, net
Operating right-of-use assets
Intangible assets, net
Goodwill
Deferred tax assets
Other long-term assets
Total Assets

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Debt for forward share purchase agreements
Notes payable due to related parties
Deferred consideration for the acquisition
Deferred consideration for the acquisition due to related parties
Lines of credit
Current portion of notes payable
Accrued liabilities
Current portion of bank and other borrowings
Deferred revenue
Preference shares
Preference shares due to related parties
Payroll and payroll related accrued liabilities
Other current liabilities
Total current liabilities

Long-term portion of bank and other borrowings
Long-term portion of notes payable
Long-term portion of notes payable due to related parties
Long-term portion of employee benefit obligation
Long-term portion of preference shares
Long-term portion of preference shares due to related parties
Deferred consideration for the acquisitions
Deferred consideration for the acquisitions due to related parties
Deferred tax liabilities
Other long-term liabilities
Total Liabilities
Common stock subject to possible redemption, 7,182,567 and 14,309,217 shares as of September 30, 2019 and 2018, respectively, at a redemption value of $10.00 per share
Stockholders’ equity:
Common stock, par value of $0.0001 per share; 100,000,000 shares authorized as of June 30, 2023 and December 31, 2022; 14,125,366 shares issued and 13,325,920 shares outstanding as of June 30, 2023 and 13,858,440 shares issued and 13,058,994 shares outstanding as of December 31, 2022
Additional paid-in capital
Treasury stock, at cost; 799,446 shares as of June 30, 2023 and December 31, 2022
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments